BridgeMD
Compares treatment options for Sick Sinus Syndrome
Official title Left Bundle Branch Versus Minimized Ventricular Pacing in Patients With Sick Sinus Syndrome and Prolonged AV Interval
ClinicalTrials.gov ID: NCT07314008
What this study is testing
- What it's testing
- The goal of this clinical trial is to compare two pacemaker strategies: Left Bundle Branch Area Pacing (LBBAP) and Minimized Ventricular Pacing (MVP) in patients requiring a permanent pacemaker for sick sinus syndrome and prolonged AV interval. It will also evaluate the safety and feasibility of the LBBAP method in these patients.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- \>18 years old
- Sinus node dysfunction with symptoms
- Atrioventricular conduction delay (PR interval \> 200ms)
You likely can't join if
- Subject was unable to provide written informed consent or participate in long-term follow-up.
- Permanent atrial fibrillation
- Pre-existing cardiac implantable electronic device
- Persistent advanced atrioventricular conduction disturbance (2:1 block, Mobitz type II, or 3rd degree)
- Mechanical tricuspid valve
- Ventricular septal defect or scar
See the full eligibility criteria
- \>18 years old
- Sinus node dysfunction with symptoms
- Atrioventricular conduction delay (PR interval \> 200ms)
- Subject was unable to provide written informed consent or participate in long-term follow-up.
- Permanent atrial fibrillation
- Pre-existing cardiac implantable electronic device
- Persistent advanced atrioventricular conduction disturbance (2:1 block, Mobitz type II, or 3rd degree)
- Mechanical tricuspid valve
- Ventricular septal defect or scar
- Left ventricular ejection fraction \< 35% who indicated cardiac resynchronization therapy
- Previous heart transplantation
- Pregnant and/or lactating women
- Life expectancy \<2 year
- Patients who are actively participating in another drug or device investigational study, which have not completed the primary endpoint follow-up period
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, Songpa-gu, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, Songpa-gu, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.